PT  - JOURNAL ARTICLE
AU  - Gater, Laura
ED  - Nauck, Michael
TI  - GLP-1 — The New Darling of Diabetes Treatment
DP  - 2006 Sep 01
TA  - MD Conference Express
PG  - 9--10
VI  - 6
IP  - 2
4099  - http://mdc.sagepub.com/content/6/2/9.short
4100  - http://mdc.sagepub.com/content/6/2/9.full
AB  - Glucagon-like peptide-1 (GLP-1) is an incretin hormone that regulates postprandial insulin secretion. The incretin effect is believed to be critical for maintenance of normal plasma glucose and glucose tolerance [Diab 1995]. Experiments using antagonists of the GLP-1 receptor show that GLP-1 is responsible for a substantial part of the insulin response to oral glucose [Diab 1995; Diab 1994]. This article discusses GLP-1 receptor agonists and DPP IV inhibitors.